JOURNAL ARTICLE

McKesson, Cencora and Cardinal Health Circle Florida Cancer Specialists.

  • Published In: Bloomberg.com, 2024. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Davis, Michelle F. 3 of 3

Abstract

Several publicly traded drug distributors, including McKesson Corp., Cencora Inc., and Cardinal Health Inc., are competing to acquire Florida Cancer Specialists & Research Institute, a privately held operator of oncology clinics. The potential deal could value Florida Cancer Specialists at over $3 billion. The company, which has been working with a financial adviser, may ultimately decide to remain independent. Florida Cancer Specialists is a leader in "value-based oncology care," where a provider takes on the cost of treating a patient in exchange for a lump sum from a health-care payer. Drug distributors have been expanding into cancer care to strengthen the distribution of specialty drugs. [Extracted from the article]

Additional Information

  • Source:Bloomberg.com. 2024/07, pN.PAG
  • Document Type:Article
  • Subject Area:Business and Management
  • Publication Date:2024
  • Accession Number:178482376
  • Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.